Sort
50,496 grants matching “lung cancer”
Clinical Trials Involving Vaccine and Standard of Care Cancer Therapies
$493,501Philip M Arlen · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Genome Sequencer FLX Instrument
$493,500Anne Virginia Kane · Tufts Medical Center · S10 · FY2010 · RR
Developmental Funds
$493,464Jennifer A Pietenpol · Vanderbilt University · P30 · FY2011 · CA
Measuring and Modulating Oxidative DNA Damage Surveillance Pathways
$493,411Eric T. Kool · Stanford University · R01 · FY2020 · CA
Circulating Tumor Cell Capture & Analysis in a Multi-Center Prostate Cancer Trial
$493,402Richard James Cote · University Of Miami School Of Medicine · R01 · FY2010 · CA
Role and Regulation of Id1 during Breast Cancer Metastasis Initiation
$493,376Robert I Benezra · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
$493,346Sourav Bandyopadhyay · University Of California, San Francisco · R01 · FY2022 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
$493,346Sourav Bandyopadhyay · University Of California, San Francisco · R01 · FY2023 · CA
Developing a Selective PROTAC of Anaplastic Lymphoma Kinase for Treatment of ALK+ NSCLC
$493,320Thomas M Huckaba · Xavier University Of Louisiana · U54 · FY2025 · MD
Using Electronic Data to Improve Care of Patients with Known or Suspected Cancer
$493,301Hardeep Singh · Baylor College Of Medicine · R18 · FY2009 · HS
Role of Formylpeptide Receptors in Host Defense
$493,225Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice
$493,144Katerina Abigail Politi · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
MODULATION OF GENE EXPRESSION BY KNOWN CHEMNOPREVENTIVE
$493,073Ohio State University · N01 · FY2000 · CN
Addressing Fugitive Chemical Health Risks through Community-Based Actions
$493,037Ramya Chari · Rand Corporation · R01 · FY2019 · ES
The use of chitosan for cancer vaccine delivery
$493,006John Greiner · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
The connection of innate and adaptive anti-cancer immunity
$493,006John Greiner · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
TASK ORDER: FURTHER TESTING OF A MULTI-PEPTIDE KRAS VACCINE FOR PANCREATIC CANCER PREVENTION
$493,001Venkateshwar Chinthalapally · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2020 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str
$492,966Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · CA
A fully automated PET radiomics framework
$492,943Abhinav K Jha · Washington University · R56 · FY2021 · EB
Project 2: OPC-NERVE
$492,852Katherine Arnold Hutcheson · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
Promoting Physical Activity in Latinas via Interactive Web-based Technology
$492,826Bess Hya Marcus · University Of California, San Diego · R01 · FY2014 · CA
Genetic Modifiers of Radiation Therapy-Induced Cardiotoxicity
$492,734Carmen Bergom · Washington University · R01 · FY2022 · HL
Solid State Beta Imaging Sensor for Radioguided Surgery
$492,729Gerald Entine · Radiation Monitoring Devices, Inc. · R44 · FY2007 · CA
Lineage heterogeneity and plasticity in lung cancer
$492,674Hideo Watanabe · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Project 3: Identifying transcriptional driver genes and targeting transcription in TSC
$492,594David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2020 · CA